Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$240.8M
+20.4% from 2023
Prescriptions
4,872
$49,425.02 per claim
Patients
947
671 prescribers
Total spending, 2024
$240.8M
$254,275.27 per patient
Medicare prescription drug plans paid $240.8M for Vyvgart in 2024, for 4,872 prescriptions and refills to 947 patients (up 20.4% from 2023). The average cost per claim was $49,425.02.
Florida had the highest Medicare cost for Vyvgart in 2024: $23.6M for 489 claims, followed by California ($22.9M).
Rocio C Garcia Santibanez, neurology in Atlanta, GA, had the highest Medicare cost for Vyvgart in 2024: 55 claims costing $3.4M.
Vyvgart is made by argenx SE (ARGX), listed in the Medicare spending data as Argenx US, Inc.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rocio C Garcia Santibanez Atlanta, GA | Neurology | 55 | Under 11 | $3.4M |
| Mario Vukic Hackensack, NJ | Neurology | 44 | Under 11 | $2.5M |
| Raji P Grewal |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 359 | 1,672 | 518 | $75.5M |
| 2023 | 577 | 4,024 | 822 | $200.0M |
| 2024 | 671 | 4,872 | 947 | $240.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 41 |
| Under 11 |
| $2.3M |
| Mamatha Pasnoor Kansas City, KS | Neurology | 42 | Under 11 | $2.2M |
| Anahit C Mehrabyan Chapel Hill, NC | Neurology | 66 | Under 11 | $2.1M |
| Jerrica Farias Tampa, FL | Nurse Practitioner | 54 | Under 11 | $2.1M |
| Marisa B McGhee Winston Salem, NC | Neurology | 36 | Under 11 | $2.1M |
| Matthew A Engelbrecht Asheville, NC | Neurology | 27 | Under 11 | $1.9M |
| Mary Sedarous Neptune, NJ | Neurology | 30 | Under 11 | $1.9M |
| Jose R Labault-Santiago Atlantis, FL | Neurology | 28 | Under 11 | $1.8M |
| Jeffrey Rosenfeld Fresno, CA | Neurology | 23 | Under 11 | $1.7M |
| Joseph N Chipman Charlotte, NC | Neurology | 22 | Under 11 | $1.6M |
| Mark A Nelson Lynbrook, NY | Neurology | 24 | Under 11 | $1.6M |
| Sukanthi Kovvuru Little Rock, AR | Neurology | 48 | Under 11 | $1.6M |
| Mohammad Alsharabati Palos Heights, IL | Neurology | 22 | Under 11 | $1.6M |
| Susan C Shin New York, NY | Neurology | 26 | Under 11 | $1.5M |
| Bashar Katirji Cleveland, OH | Neurology | 25 | Under 11 | $1.4M |
| Shawn J Bird Philadelphia, PA | Neurology | 43 | Under 11 | $1.3M |
| Robert F Armstrong Asheville, NC | Neurology | 19 | Under 11 | $1.3M |
| Sarah M Heintzman Columbus, OH | Nurse Practitioner | 23 | Under 11 | $1.3M |
| Srikanth Muppidi Stanford, CA | Neurology | 28 | Under 11 | $1.3M |
| Naiara Alvarez Harlingen, TX | Rheumatology | 18 | Under 11 | $1.3M |
| Mayank Mathur Lumberton, NJ | Neurology | 20 | Under 11 | $1.3M |
| Xiaowei W Su Hershey, PA | Neurology | 17 | Under 11 | $1.3M |
| Sadiq L Altamimi Pomona, CA | Neurology | 22 | Under 11 | $1.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Argenx US, Inc ARGX | 4,872 | $240.8M |